For example, in the STEP 1 trial extension, patients who stopped semaglutide after 68 weeks of treatment regained about two thirds of the weight they had lost within one year of discontinuation
doi: 10.1007/s10571-017-0469-1 Summary Keywords sinomenine, cerebral ischemia, drug delivery, neuroinflammation, bonebrainaxis Citation Li X, Zhang X, Wang T, Li H, Li Y, Liu J and Bai Y (2025) Sinomenine in cerebral ischemia: mechanisms, delivery strategies, and the emerging multifunctional biomaterials of the bonebrain axis
TKT and TKTL1 rather than TKTL2 are essential for promoting cell growth and reducing oxidative stress in cancer cells (106, 107)
This means it works differently from GLP-1-only medicines and dual agonist medicines
And it was done for money